MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 21 filers reported holding MARRONE BIO INNOVATIONS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,435,000 | -7.1% | 1,236,946 | -13.5% | 0.00% | – |
| Q1 2022 | $1,545,000 | +65.1% | 1,430,799 | +10.1% | 0.00% | – |
| Q4 2021 | $936,000 | -21.1% | 1,299,905 | -1.2% | 0.00% | – |
| Q3 2021 | $1,186,000 | -41.5% | 1,315,914 | +7.7% | 0.00% | – |
| Q2 2021 | $2,029,000 | -3.1% | 1,222,391 | +22.0% | 0.00% | – |
| Q1 2021 | $2,094,000 | +71.4% | 1,001,879 | +2.5% | 0.00% | – |
| Q4 2020 | $1,222,000 | +49.8% | 977,871 | +46.2% | 0.00% | – |
| Q3 2020 | $816,000 | +11.6% | 669,048 | +7.1% | 0.00% | – |
| Q2 2020 | $731,000 | +8.5% | 624,864 | -24.2% | 0.00% | – |
| Q1 2020 | $674,000 | -17.5% | 824,551 | +1.9% | 0.00% | – |
| Q4 2019 | $817,000 | -24.6% | 808,826 | +5.3% | 0.00% | – |
| Q3 2019 | $1,083,000 | -7.4% | 767,887 | -1.5% | 0.00% | – |
| Q2 2019 | $1,169,000 | -6.3% | 779,620 | -4.3% | 0.00% | – |
| Q1 2019 | $1,247,000 | -7.0% | 814,912 | -10.6% | 0.00% | – |
| Q4 2018 | $1,341,000 | -16.7% | 911,934 | +3.7% | 0.00% | – |
| Q3 2018 | $1,609,000 | +8.3% | 879,034 | +8.8% | 0.00% | – |
| Q2 2018 | $1,486,000 | +6654.5% | 807,871 | +7380.3% | 0.00% | – |
| Q1 2018 | $22,000 | +83.3% | 10,800 | 0.0% | 0.00% | – |
| Q4 2017 | $12,000 | 0.0% | 10,800 | 0.0% | 0.00% | – |
| Q3 2017 | $12,000 | -14.3% | 10,800 | 0.0% | 0.00% | – |
| Q2 2017 | $14,000 | -33.3% | 10,800 | 0.0% | 0.00% | – |
| Q1 2017 | $21,000 | -8.7% | 10,800 | 0.0% | 0.00% | – |
| Q4 2016 | $23,000 | +21.1% | 10,800 | 0.0% | 0.00% | – |
| Q3 2016 | $19,000 | +111.1% | 10,800 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | -10.0% | 10,800 | 0.0% | 0.00% | – |
| Q1 2016 | $10,000 | -16.7% | 10,800 | 0.0% | 0.00% | – |
| Q4 2015 | $12,000 | -47.8% | 10,800 | 0.0% | 0.00% | – |
| Q3 2015 | $23,000 | -58.9% | 10,800 | -62.1% | 0.00% | – |
| Q2 2015 | $56,000 | -87.8% | 28,500 | -75.9% | 0.00% | – |
| Q1 2015 | $459,000 | +11.7% | 118,389 | +3.9% | 0.00% | – |
| Q4 2014 | $411,000 | +83.5% | 113,977 | +35.5% | 0.00% | – |
| Q3 2014 | $224,000 | -69.5% | 84,143 | +33.0% | 0.00% | – |
| Q2 2014 | $735,000 | -1.2% | 63,251 | +18.6% | 0.00% | – |
| Q1 2014 | $744,000 | -7.5% | 53,342 | +18.2% | 0.00% | – |
| Q4 2013 | $804,000 | +36.5% | 45,124 | +28.9% | 0.00% | – |
| Q3 2013 | $589,000 | – | 35,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 14,303,099 | $15,635,000 | 3.02% |
| ICM ASSET MANAGEMENT INC/WA | 21,500 | $26,000 | 0.14% |
| Fairpointe Capital LLC | 613,900 | $749,000 | 0.12% |
| WADDELL & REED FINANCIAL INC | 25,095,634 | $30,617,000 | 0.07% |
| WEDBUSH SECURITIES INC | 37,129 | $45,000 | 0.00% |
| Financial Advocates Investment Management | 30,925 | $38,000 | 0.00% |
| PRIMECAP MANAGEMENT CO/CA/ | 2,035,300 | $2,483,000 | 0.00% |
| Avior Wealth Management, LLC | 10,000 | $12,000 | 0.00% |
| AMALGAMATED BANK | 10,217 | $12,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 73,897 | $90,000 | 0.00% |